Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Ultrasonographic evidence of a...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Ultrasonographic evidence of attenuated joint destruction within 18 weeks in early RA patients treated with infliximab.

Ultrasonographic evidence of attenuated joint destruction within 18 weeks in early RA patients treated with infliximab.

Bibliographic Details
Main Authors: Taylor, P, Steuer, A, Gruber, J, McClinton, C, Cosgrove, D, Blomley, M, Wagner, C, Marsters, P, Maini, R
Format: Conference item
Published: 2003
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • JOINT DESTRUCTION IS ATTENUATED BY INFLIXIMAB IN EARLY RA PATIENTS WITH ULTRASONOGRAPHIC MARKERS OF POOR PROGNOSIS
    by: Taylor, P, et al.
    Published: (2003)
  • Infliximab attenuates joint destruction in early RA patients with ultrasonographic markers of poor prognosis.
    by: Taylor, P, et al.
    Published: (2002)
  • Ultrasonographic and radiographic evidence of attenuated joint destruction in early RA patients treated with infliximab
    by: Taylor, P, et al.
    Published: (2003)
  • SIGNIFICANT CHANGES IN SONOGRAPHIC MEASURES OF JOINT VASCULARITY AND SERUM VEGF IN EARLY RA PATIENTS ON INFLIXIMAB BY 18 WEEKS OF THERAPY
    by: Taylor, P, et al.
    Published: (2002)
  • Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis.
    by: Taylor, P, et al.
    Published: (2004)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs